HALOZYME THERAPEUTICS Trademark

Trademark Overview

On Thursday, April 22, 2010, a trademark application was filed for HALOZYME THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the HALOZYME THERAPEUTICS trademark a serial number of 85021005. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 6, 2020. This trademark is owned by Halozyme, Inc.. The HALOZYME THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Enzymes for medical purposes, namely, facilitating delivery of pharmaceuticals, and pharmaceuticals containing enzymes to facilitate delivery of a wide range of pharmaceuticals; drug delivery agents that facilitate delivery of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments
halozyme therapeutics

General Information

Serial Number85021005
Word MarkHALOZYME THERAPEUTICS
Filing DateThursday, April 22, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 6, 2020
Registration Number4376776
Registration DateTuesday, July 30, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2010

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesEnzymes for medical purposes, namely, facilitating delivery of pharmaceuticals, and pharmaceuticals containing enzymes to facilitate delivery of a wide range of pharmaceuticals; drug delivery agents that facilitate delivery of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 6, 2020
Primary Code005
First Use Anywhere DateThursday, April 25, 2013
First Use In Commerce DateThursday, April 25, 2013

Trademark Owner History

Party NameHalozyme, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameHalozyme, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameHalozyme, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, March 6, 2020CANCELLED SEC. 8 (6-YR)
Monday, July 30, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 22, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 29, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 19, 2016REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Monday, January 11, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 30, 2014REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Friday, June 27, 2014TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 30, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, June 26, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, June 25, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 18, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 3, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 16, 2013USE AMENDMENT FILED
Thursday, May 16, 2013TEAS STATEMENT OF USE RECEIVED
Friday, November 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, November 8, 2012EXTENSION 4 GRANTED
Wednesday, November 7, 2012EXTENSION 4 FILED
Wednesday, November 7, 2012TEAS EXTENSION RECEIVED
Saturday, June 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, June 1, 2012EXTENSION 3 GRANTED
Wednesday, May 23, 2012EXTENSION 3 FILED
Wednesday, May 23, 2012TEAS EXTENSION RECEIVED
Wednesday, November 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 1, 2011EXTENSION 2 GRANTED
Monday, October 31, 2011EXTENSION 2 FILED
Tuesday, November 1, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 31, 2011TEAS EXTENSION RECEIVED
Saturday, May 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 5, 2011EXTENSION 1 GRANTED
Thursday, May 5, 2011EXTENSION 1 FILED
Thursday, May 5, 2011TEAS EXTENSION RECEIVED
Tuesday, November 23, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2010PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2010NOTICE OF PUBLICATION
Tuesday, August 24, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 24, 2010ASSIGNED TO LIE
Monday, August 9, 2010EXAMINER'S AMENDMENT MAILED
Friday, August 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 6, 2010EXAMINER'S AMENDMENT ENTERED
Friday, August 6, 2010EXAMINERS AMENDMENT -WRITTEN
Monday, August 2, 2010ASSIGNED TO EXAMINER
Wednesday, April 28, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 26, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics halozyme pharmaceuticals disorders delivery conditions preparations pharmaceutical treatment facilitate enzymes complications